A 65-year-old man with oligometastatic prostate cancer underwent radical prostatectomy and stereotactic body radiation therapy (SBRT) to a right pubic bone metastasis. Four weeks after SBRT, PSMA PET showed increased extent and intensity of uptake at the treated site, despite a 92% PSA decline (8.5 to 0.7 ng/mL) and no new lesions. Later imaging confirmed resolution of uptake, consistent with bone flare, but revealed multiple new osseous metastases and rising PSA (2.8 ng/mL), indicating progression. To our knowledge, this is the first reported case of SBRT-induced bone flare, highlighting the need for cautious interpretation of early posttreatment PSMA PET.
Building similarity graph...
Analyzing shared references across papers
Loading...
Marulanda-Corzo et al. (Tue,) studied this question.
synapsesocial.com/papers/69d8967d6c1944d70ce07e8c — DOI: https://doi.org/10.1097/rlu.0000000000006447
Valentina Marulanda-Corzo
Cornell University
Preeti Kakkar
Cornell University
Arman Sharbatdaran
Cornell University
Clinical Nuclear Medicine
Cornell University
Presbyterian Hospital
Lander Institute
Building similarity graph...
Analyzing shared references across papers
Loading...
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: